Treatment of Hepatitis C in Hemophilic Patients With HIV
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
Pegylated interferon (PEG-interferon) and ribavirin are accepted treatments for hepatitis C
virus (HCV) infection. However, HCV infection progresses differently in patients who are
coinfected with HIV and in hemophiliacs. This study will evaluate the effectiveness of
PEG-interferon and ribavirin for treating HCV in HIV infected hemophiliacs.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)